Medical Research Commercialisation Fund is an institutional investor (Conventional VCs) founded in 2007 and headquartered in Melbourne, Australia. Medical Research Commercialisation Fund is a seed & early stage focused venture capital investment company. Geographies of interest include Australia. Finances companies engaged in life sciences companies specializing in Drug Discovery & Development, Biopharma, Medical Devices and BioTech. Top investments include Vaxxas, OncoRes Medical, Fibrotech Therapeutics, Auspherix. Notable portfolio companies: Vaxxas, OncoRes Medical, Fibrotech Therapeutics, Auspherix.

Stage

proof-of-concept, early-stage, clinical-stage, late-stage, proof-of-concept, early-stage, clinical-stage, late-stage

Check size

AU$500K - AU$30M

HQ

Melbourne, Australia

Founded

2007

Website

http://mrcf.com.au

LinkedIn

https://linkedin.com/company/the-medical-research-commercialisation-fund

Twitter

https://twitter.com/blockcraftersvc

What they look for

Opportunities originating from member medical research institutes and hospitals in Australia and New Zealand; strong commercial potential in biomedical innovations

Preparing to pitch Medical Research Commercialisation Fund?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.